Current liabilities increased 67.4%
Current liabilities changed +67.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$1.6B→$2.6B4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →KEYS financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Trade receivables increased 54.2%
Trade receivables changed +54.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$692.0M→$1.1B4 prior comparisons
Operating margin moved 767 bp higher
Operating margin changed +767 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
17.31%→24.97%2 prior comparisons
Working capital decreased 33.9%
Working capital changed -33.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$4.0B→$2.7B4 prior comparisons
Operating income increased 97.0%
Operating income changed +97.0% from the comparable as-filed period.
$234.0M→$461.0M2 prior comparisons
Free-cash-flow proxy increased 38.5%
Free-cash-flow proxy changed +38.5% from the comparable as-filed period.
$291.0M→$403.0M2 prior comparisons
Operating cash flow increased 35.7%
Operating cash flow changed +35.7% from the comparable as-filed period.
$322.0M→$437.0M2 prior comparisons
Net income increased 107.9%
Net income changed +107.9% from the comparable as-filed period.
$191.0M→$397.0M2 prior comparisons
Revenue increased 36.5%
Revenue changed +36.5% from the comparable as-filed period.
$1.4B→$1.8B2 prior comparisons
Current ratio decreased 43.7%
Current ratio changed -43.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
3.59→2.024 prior comparisons
Working capital / assets moved 1554 bp lower
Working capital / assets changed -1554 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
37.97%→22.43%4 prior comparisons
Total assets increased 11.9%
Total assets changed +11.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$10.7B→$11.9B4 prior comparisons
Debt / assets moved 267 bp lower
Debt / assets changed -267 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
23.78%→21.11%4 prior comparisons
Inventory / revenue moved 1880 bp lower
Inventory / revenue changed -1880 basis points from the comparable as-filed period.
75.52%→56.72%2 prior comparisons
Noncurrent long-term debt decreased 28.3%
Noncurrent long-term debt changed -28.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$2.5B→$1.8B4 prior comparisons
Research & development increased 24.8%
Research & development changed +24.8% from the comparable as-filed period.
$250.0M→$312.0M2 prior comparisons
Debt / revenue moved 5100 bp lower
Debt / revenue changed -5100 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
187.35%→136.35%2 prior comparisons
Receivables / revenue moved 662 bp higher
Receivables / revenue changed +662 basis points from the comparable as-filed period.
51.18%→57.80%2 prior comparisons
Stock-based compensation increased 46.9%
Stock-based compensation changed +46.9% from the comparable as-filed period.
$32.0M→$47.0M2 prior comparisons
Selling, general & administrative increased 26.0%
Selling, general & administrative changed +26.0% from the comparable as-filed period.
$354.0M→$446.0M2 prior comparisons
Operating cash flow / net income decreased 34.7%
Operating cash flow / net income changed -34.7% from the comparable as-filed period.
1.69→1.12 prior comparisons
R&D / revenue moved 159 bp lower
R&D / revenue changed -159 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
18.49%→16.90%2 prior comparisons
Capex / revenue moved 45 bp lower
Capex / revenue changed -45 basis points from the comparable as-filed period.
2.29%→1.84%2 prior comparisons
Net debt increased 14.6%
Net debt changed +14.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
-$103.0M→-$88.0M4 prior comparisons
Current assets decreased 5.7%
Current assets changed -5.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$5.6B→$5.3B4 prior comparisons
Shares outstanding decreased 0.9%
Shares outstanding changed -0.9% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
171,856,249→170,244,7458 prior comparisons
Capital expenditure increased 9.7%
Capital expenditure changed +9.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$31.0M→$34.0M2 prior comparisons
Gross debt decreased 0.6%
Gross debt changed -0.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$2.5B→$2.5B4 prior comparisons
Reported total debt decreased 0.6%
Reported total debt changed -0.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$2.5B→$2.5B4 prior comparisons
SBC / revenue moved 18 bp higher
SBC / revenue changed +18 basis points from the comparable as-filed period.
2.37%→2.55%2 prior comparisons
Inventory increased 2.5%
Inventory changed +2.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$1.0B→$1.0B4 prior comparisons
Cash & equivalents decreased 1.2%
Cash & equivalents changed -1.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$2.6B→$2.6B4 prior comparisons
Cash / debt moved 57 bp lower
Cash / debt changed -57 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
104.07%→103.50%4 prior comparisons
Free-cash-flow margin moved 31 bp higher
Free-cash-flow margin changed +31 basis points from the comparable as-filed period.
21.52%→21.83%2 prior comparisons
Operating cash-flow margin moved 14 bp lower
Operating cash-flow margin changed -14 basis points from the comparable as-filed period.
23.82%→23.67%2 prior comparisons
Cash & equivalents decreased 22.6%
Cash & equivalents changed -22.6% from the comparable as-filed period.
$3.1B→$2.4B0 prior comparisons
Net income increased 35.8%
Net income changed +35.8% from the comparable as-filed period.
$257.0M→$349.0M0 prior comparisons
Operating income increased 96.6%
Operating income changed +96.6% from the comparable as-filed period.
$207.0M→$407.0M0 prior comparisons
Operating margin increased by 7.85 points
Operating margin moved +7.85 percentage points from the comparable as-filed period.
15.85%→23.70%0 prior comparisons
Research & development increased 28.0%
Research & development changed +28.0% from the comparable as-filed period.
$250.0M→$320.0M0 prior comparisons
Revenue increased 31.5%
Revenue changed +31.5% from the comparable as-filed period.
$1.3B→$1.7B0 prior comparisons
Selling, general & administrative increased 26.7%
Selling, general & administrative changed +26.7% from the comparable as-filed period.
$360.0M→$456.0M0 prior comparisons
Stock-based compensation increased 56.8%
Stock-based compensation changed +56.8% from the comparable as-filed period.
$37.0M→$58.0M0 prior comparisons
Debt decreased 0.0%
Debt changed -0.0% from the comparable as-filed period.
$2.5B→$2.5B0 prior comparisons
Inventory increased 1.2%
Inventory changed +1.2% from the comparable as-filed period.
$1.0B→$1.0B0 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.